PER
Click for more information
5.13% 7.4¢ percheron therapeutics limited

To me the issue may well be safety rather than efficacy for this...

  1. Quay Street
    463 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    22/06/22
    08:34
    Post #: 62127415
    To me the issue may well be safety rather than efficacy for this drug.
    MS did not demonstrate any safety issues but lack of clininical effectiveness. Am I right?
    ANP Price at posting: 9.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢ 		Change
-0.004(5.13%) 		Mkt cap ! $66.71M
Open High Low Value Volume
7.8¢ 7.8¢ 7.2¢ $78.26K 1.049M

Buyers (Bids)

No. Vol. Price($)
1 5919 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 156164 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.